Jba 5mg/10mg Tablet is a combination medication containing Levocetirizine 5mg and Montelukast 10mg, indicated for the management of allergic conditions such as allergic rhinitis and chronic urticaria. Levocetirizine is a potent, selective antagonist of peripheral H1 histamine receptors, providing effective relief from symptoms including sneezing, nasal congestion, itching, and rhinorrhea by inhibiting the action of histamine. Montelukast, a leukotriene receptor antagonist, blocks the cysteinyl leukotriene receptor, thereby reducing inflammation, bronchoconstriction, and mucus production associated with allergic responses and asthma. The synergistic action of these agents offers comprehensive control of allergic symptoms and improves patient quality of life. Jba 5mg/10mg Tablet is typically administered once daily, with or without food, as prescribed by a healthcare professional. It is generally well tolerated; however, patients should be monitored for potential adverse effects such as headache, fatigue, gastrointestinal disturbances, or neuropsychiatric events. Use is contraindicated in individuals with known hypersensitivity to either component. This combination therapy is not intended for acute asthma attacks and should be used under medical supervision, particularly in patients with hepatic or renal impairment. Jba 5mg/10mg Tablet provides an effective therapeutic option for long-term management of allergic disorders.